173 related articles for article (PubMed ID: 17951196)
1. Expression of p63 in cutaneous metastases.
Kanitakis J; Chouvet B
Am J Clin Pathol; 2007 Nov; 128(5):753-8. PubMed ID: 17951196
[TBL] [Abstract][Full Text] [Related]
2. Use of p63 expression in distinguishing primary and metastatic cutaneous adnexal neoplasms from metastatic adenocarcinoma to skin.
Ivan D; Nash JW; Prieto VG; Calonje E; Lyle S; Diwan AH; Lazar AJ
J Cutan Pathol; 2007 Jun; 34(6):474-80. PubMed ID: 17518775
[TBL] [Abstract][Full Text] [Related]
3. Value of p63 and podoplanin (D2-40) immunoreactivity in the distinction between primary cutaneous tumors and adenocarcinomas metastatic to the skin: a clinicopathologic and immunohistochemical study of 79 cases.
Plaza JA; Ortega PF; Stockman DL; Suster S
J Cutan Pathol; 2010 Apr; 37(4):403-10. PubMed ID: 20377670
[TBL] [Abstract][Full Text] [Related]
4. Expression of p63 normal canine skin and primary cutaneous glandular carcinomas.
Saraiva AL; Gärtner F; Pires MA
Vet J; 2008 Jul; 177(1):136-40. PubMed ID: 17804265
[TBL] [Abstract][Full Text] [Related]
5. Expression profiles of p63, p53, survivin, and hTERT in skin tumors.
Park HR; Min SK; Cho HD; Kim KH; Shin HS; Park YE
J Cutan Pathol; 2004 Sep; 31(8):544-9. PubMed ID: 15268709
[TBL] [Abstract][Full Text] [Related]
6. Assessment of p63 expression in the salivary gland neoplasms adenoid cystic carcinoma, polymorphous low-grade adenocarcinoma, and basal cell and canalicular adenomas.
Edwards PC; Bhuiya T; Kelsch RD
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 May; 97(5):613-9. PubMed ID: 15153875
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical expression of p63 in pleomorphic adenomas and carcinomas ex-pleomorphic adenomas of salivary glands.
Genelhu MC; Gobbi H; Soares FA; Campos AH; Ribeiro CA; Cassali GD
Oral Oncol; 2006 Feb; 42(2):154-60. PubMed ID: 16256413
[TBL] [Abstract][Full Text] [Related]
8. p63 overexpression associates with poor prognosis in head and neck squamous cell carcinoma.
Lo Muzio L; Santarelli A; Caltabiano R; Rubini C; Pieramici T; Trevisiol L; Carinci F; Leonardi R; De Lillo A; Lanzafame S; Bufo P; Piattelli A
Hum Pathol; 2005 Feb; 36(2):187-94. PubMed ID: 15754296
[TBL] [Abstract][Full Text] [Related]
9. p63 immunoreactivity in lung cancer: yet another player in the development of squamous cell carcinomas?
Pelosi G; Pasini F; Olsen Stenholm C; Pastorino U; Maisonneuve P; Sonzogni A; Maffini F; Pruneri G; Fraggetta F; Cavallon A; Roz E; Iannucci A; Bresaola E; Viale G
J Pathol; 2002 Sep; 198(1):100-9. PubMed ID: 12210069
[TBL] [Abstract][Full Text] [Related]
10. The use of p63 as an effective immunomarker in the diagnosis of pulmonary squamous cell carcinomas on de-stained bronchial lavage cytological smears.
Uke M; Rekhi B; Ajit D; Jambhekar NA
Cytopathology; 2010 Feb; 21(1):56-63. PubMed ID: 19744186
[TBL] [Abstract][Full Text] [Related]
11. Primary mucoepidermoid carcinoma of the skin expressing p63.
Suárez-Peñaranda JM; Vieites B; Valeiras E; Varela-Duran J
Am J Dermatopathol; 2010 Feb; 32(1):61-4. PubMed ID: 19786853
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical staining for p63 is useful in the diagnosis of anal squamous cell carcinomas.
Owens SR; Greenson JK
Am J Surg Pathol; 2007 Feb; 31(2):285-90. PubMed ID: 17255774
[TBL] [Abstract][Full Text] [Related]
13. p63 in Primary Cutaneous Carcinosarcoma.
Suh KY; Lacouture M; Gerami P
Am J Dermatopathol; 2007 Aug; 29(4):374-7. PubMed ID: 17667171
[TBL] [Abstract][Full Text] [Related]
14. Value of p63 and cytokeratin 5/6 as immunohistochemical markers for the differential diagnosis of poorly differentiated and undifferentiated carcinomas.
Kaufmann O; Fietze E; Mengs J; Dietel M
Am J Clin Pathol; 2001 Dec; 116(6):823-30. PubMed ID: 11764070
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathologic correlation of cutaneous metastases: experience from a cancer center.
Sariya D; Ruth K; Adams-McDonnell R; Cusack C; Xu X; Elenitsas R; Seykora J; Pasha T; Zhang P; Baldassano M; Lessin SR; Wu H
Arch Dermatol; 2007 May; 143(5):613-20. PubMed ID: 17515511
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical techniques to compare primary vs. metastatic mucinous carcinoma of the skin.
Levy G; Finkelstein A; McNiff JM
J Cutan Pathol; 2010 Apr; 37(4):411-5. PubMed ID: 19788442
[TBL] [Abstract][Full Text] [Related]
17. Adenosquamous carcinoma: a report of nine cases with p63 and cytokeratin 5/6 staining.
Ko CJ; Leffell DJ; McNiff JM
J Cutan Pathol; 2009 Apr; 36(4):448-52. PubMed ID: 19278431
[TBL] [Abstract][Full Text] [Related]
18. Effect of p63 expression on survival in oral squamous cell carcinoma.
Lo Muzio L; Campisi G; Farina A; Rubini C; Pastore L; Giannone N; Colella G; Leonardi R; Carinci F
Cancer Invest; 2007 Sep; 25(6):464-9. PubMed ID: 17882659
[TBL] [Abstract][Full Text] [Related]
19. Expression of p63 in primary cutaneous adnexal neoplasms and adenocarcinoma metastatic to the skin.
Ivan D; Hafeez Diwan A; Prieto VG
Mod Pathol; 2005 Jan; 18(1):137-42. PubMed ID: 15389254
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of monoclonal antibody HIK1083 specific for gastric O-glycan in differentiating cutaneous metastasis of gastric cancer from primary sweat gland carcinoma.
Iijima M; Nakayama J; Nishizawa T; Ishida A; Ishii K; Ota H; Katsuyama T; Saida T
Am J Dermatopathol; 2007 Oct; 29(5):452-6. PubMed ID: 17890913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
